公众号 / 文章心脑血管急症重症综合管理与镇静镇痛

我们准备好基于脑自动调节进行临床治疗了吗?正反方辩论

Are We Ready for Clinical Therapy based on Cerebral Autoregulation? A Pro-con Debate.
PubMed 文献 · Neurocrit Care · 2023-05-10
一句话结论脑自动调节导向治疗缺乏强证据支持改善结局,目前尚未能转化为临床实践。

本文以正反方辩论形式审视脑自动调节(CA)监测技术与连续评估的准确性,以及近年临床试验对CA认识的推进。尽管CA导向的临床干预尚未显示明确临床获益,缺乏影响结局的强证据使CA导向算法未能转化为临床实践。文章强调在设计未来试验时需理解无法产生强证据的根本原因,并讨论了CA知识增加对理解多种疾病继发性脑损伤的意义。

要点

  • CA是维持脑血流恒定、防止低灌注或高灌注脑损伤的生理机制。
  • 提出的优化自动调节状态的临床干预尚未显示明确临床获益。
  • 缺乏影响结局的强证据已阻碍CA导向算法转化为临床实践。
  • 未来试验设计需理解无法产生强临床证据支持CA导向管理的根本原因。
  • 近年临床试验增加的CA知识有助于理解多种疾病过程中的继发性脑损伤。

研究设计与关键结果

  • 本文为针对基于脑自动调节的临床治疗是否准备好的正反方辩论文章。
  • 近年研究探讨了全身血压范围和临床管理策略,脑血管在此范围内调节颅内血流动力学以维持脑灌注。
  • 提出的优化自动调节状态的临床干预尚未显示明确临床获益。
  • 缺乏影响结局的强证据已使CA导向算法未能转化为临床实践。
  • 近年临床试验增加的CA知识有助于更深入理解多种疾病过程中的继发性脑损伤。

证据类型、等级与局限

  • 证据类型:正反方辩论文章。
  • 局限:原文未报告局限性

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Cerebral autoregulation (CA) is a physiological mechanism that maintains constant cerebral blood flow regardless of changes in cerebral perfusion pressure and prevents brain damage caused by hypoperfusion or hyperperfusion. In recent decades, researchers have investigated the range of systemic blood pressures and clinical management strategies over which cerebral vasculature modifies intracranial hemodynamics to maintain cerebral perfusion. However, proposed clinical interventions to optimize autoregulation status have not demonstrated clear clinical benefit. As future trials are designed, it is crucial to comprehend the underlying cause of our inability to produce robust clinical evidence supporting the concept of CA-targeted management. This article examines the technological advances in monitoring techniques and the accuracy of continuous assessment of autoregulation techniques used in intraoperative and intensive care settings today. It also examines how increasing knowledge of CA from recent clinical trials contributes to a greater understanding of secondary brain injury in many disease processes, despite the fact that the lack of robust evidence influencing outcomes has prevented the translation of CA-guided algorithms into clinical practice.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Sarwal A, Robba C, Venegas C, et al. Are We Ready for Clinical Therapy based on Cerebral Autoregulation? A Pro-con Debate. Neurocrit Care. 2023. PMID: 37165296. doi:10.1007/s12028-023-01741-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。